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Abstract
Background: Brucellosis is a bacterial disease caused by Brucella infection. In the late fifties, Brucella suis vaccine
strain S2 with reduced virulence was obtained by serial transfer of a virulent B. suis biovar 1 strain in China. It has
been widely used for vaccination in China since 1971. Until now, the mechanisms underlie virulence attenuation of
S2 are still unknown.
Results: In this paper, the whole genome sequencing of S2 was carried out by Illumina Hiseq2000 sequencing
method. We further performed the comparative genomic analysis to find out the differences between S2 and the
virulent Brucella suis strain 1330. We found premature stops in outer membrane autotransporter omaA and eryD
genes. Single mutations were found in phosphatidylcholine synthase, phosphorglucosamine mutase, pyruvate
kinase and FliF, which have been reported to be related to the virulence of Brucella or other bacteria. Of the other
different proteins between S2 and 1330, such as Omp2b, periplasmic sugar-binding protein, and oligopeptide ABC
transporter, no definitive implications related to bacterial virulence were found, which await further investigation.
Conclusions: The data presented here provided the rational basis for designing Brucella vaccines that could be
used in other strains.
Keywords: Brucella suis vaccine strain S2, Brucella suis virulent strain 1330, Genome sequence, Comparative
genomic analysis
Background
Brucellosis is a worldwide zoonotic disease caused by the
infection of Brucella species, a Gram-negative and faculta-
tive intracellular bacterium. Brucellosis can be acquired by
direct contact with infected animals including cattle,
sheep, goats and swine. Brucella infects approximately
500,000 humans worldwide annually according to the
World Health Organization (WHO) [1]. The infection can
cause reproductive failure in food animals and even the
loss of human productivity. The clinical symptoms of Bru-
cella infection include undulant fever, abortion, asthenia,
endocarditis, and encephalitis. Brucellosis in food animals
could be controlled by vaccination, while human brucel-
losis can be treated with antibiotics.
Currently, there are ten recognized Brucella species
based on their host preference and phenotypic differences:
B. melitensis (goats), B. abortus (cattle), B. suis (swine), B.
canis (dogs), B. ovis (sheep), B. neotomae (desert mice), B.
ceti (cetaceans), B. pinnipedialis (pinnipeds), B. microti
(common voles) and B. inopinata (unknown) [2]. The
genome of B. melitensis strain 16M is the first one to
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be sequenced [3], followed by B. suis strain 1330 [4, 5]
and B. abortus strain 2308 and 9–941 [6]. New Brucella
genome sequences are increasing, and at least 39 Brucella
strains have been sequenced. These genomic resources
can be served for identifying Brucella gene variability that
associated with their host preference, pathogenesis, and
virulence.
B. suis strain 1330 (hereafter referred to as 1330) is a
swine isolate and used as the standard reference strain for
B. suis biovar 1 [7]. According to phylogenetic analysis of
10 Brucella strains, B. suis has a broader host specificity
without any identified species-specific markers [8].
The B. suis strain S2 is isolated from swine fetus by
the Institute of Inspection for Veterinary Medicine in
1952 in China. It possesses all of the characteristics of B.
suis biovar 1 and a smooth colonial morphology [9].
After serial transfer on media for years, B. suis strain S2
is naturally attenuated to a vaccine strain designated as
B. suis vaccine “strain 2” or S2 (hereafter referred to as
S2). The avirulent property of S2 is stable when inoculated
into susceptible animals, and it does not cause the abor-
tion of pregnant female [9]. Therefore, it has been widely
used in China since 1971 to vaccinate sheep and goats [9].
The vaccine is administered through drinking water, a
dose of 10 billion bacteria provides the protection for 2–3
years. In the middle of 1980s, S2 is introduced to the other
countries [10]. Although studies suggest that the protec-
tion rate of S2 is less than that of B. abortus “strain 19” or
S19 (hereafter referred to as S19) and B. melitensis Rev. 1
(hereafter referred to as Rev. 1) [11, 12], a large-scale ani-
mal test shows that S2 can provide a satisfactory protec-
tion rate in the field [9, 13]. Based on these encouraging
results, the low virulence compared with S19 and Rev.1,
the low cost of production, the safety for pregnant sheep
and the feasibility of administration by the oral route in
cattle, pigs, sheep and goats, S2 is used successfully in
China to vaccinate all target species against brucellosis by
administration through drinking water [9–12]. In mice, S2
has low residual virulence and less persistence time com-
pared with S19 and Rev.1. It provides short-time protec-
tion against virulence B. melitensis challenge compared
with the other two vaccines [14]. However, it does not
show significant protection against B. melitensis 53H38
challenge when tested in lambs [11].
The underlying molecular and physiological mecha-
nisms of the low virulence of S2 are not well understood
so far. In this study, we performed the paired-end se-
quencing combined with Sanger sequencing method to
determine the complete genome sequences of S2. We
further identified the different genes between S2 and
1330 by genome comparison. Several putative factors
were identified as the candidate genes that might be
related to the virulence attenuation of S2. Further in-
vestigation of these target genes will be important for




The S2 genome was comprised of two circular chromo-
somes (Table 1). One chromosome was 2,107,842 bp and
the other was 1,207,433 bp long in length. The average GC
content of the two chromosomes was 57 %. Unsurprisingly,
The S2 genomes exhibited significant similarities in size
and structure compared to the genomic sequences of 1330.
The S2 genome sequences showed over 99.9 % similarities
with the genomes of 1330. The diagram of S2 genomes is
shown in Fig. 1. Circos was employed to construct the dia-
gram [15]. A total of 2119 and 1139 open reading frames
(ORFs) were identified on chromosome I and II, respect-
ively. Sequences of these two chromosomes can be accessed
from GenBank (CP006961 and CP006962). More than
99.5 % of ORFs in S2 were identical to those found in
1330 (CP002997.1 and CP002998.1). S2 exhibited highly
genome-wide collinearity with 1330 (Fig. 2 and Additional
file 1: Table S1). More than 38 % of the predicted ORFs in
S2 had rpsblast hits to the cluster of orthologous groups
(COG) database with an e-value less than 1e-2. A total of
1147 ORFs (35.2 %) were hypothetical proteins (Table 1).
Genome-wide comparison between S2 and 1330 ge-
nomes identified all the single nucleotide polymorphisms
(SNPs), a total of 72 SNPs were identified (Table 2). The
SNPs were not equally distributed between the two chro-
mosomes, 42 SNPs (58 %) were located on chromosome I,
while the remaining 30 SNPs (42 %) were located on
chromosome II. The exact positions of all of the SNPs at
the nucleotide level and protein level (if the SNP is within
an ORF) are shown in Additional file 2: Table S2. Twenty-
two SNPs (31 %) were located in intergenic regions. Fifty
SNPs were located within a total of 48 different ORFs
(Table 3). Ten were synonymous substitutions; 39 were
Table 1 Genome properties of the newly sequenced genome
of B. suis strain S2 in comparison with the known genome
sequence of B. suis strain 1330
B. suis strain 2 B. suis 1330
Feature/Property ChrI ChrII ChrI ChrII
ORFs 2119 1139 2122 1144
tRNAs 41 14 41 14
rRNAs 8 4 8 4
Size(bp) 2107842 1207433 2107794 1207381
GC(%) 57.21 57.32 57.21 57.32
Average gene length(bp) 836.28 892.23 836.86 894.46
Coding(%) 84.07 84.17 84.20 84.75
Hypothetical proteins 794 353 796 353
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non-synonymous substitutions; one SNP caused either fra-
meshifting or premature stop in protein coding region.
Putative protein-encoding genes, tRNA and rRNA in S2
genome were predicted with RAST (http://rast.nmpdr.org).
The predicted protein sequences were compared with non-
redundant protein database. The protein sequences were
also compared with COG and CDD database, the threshold
is E < 1e-2.
Identification of virulence associated differences between
the attenuated strain S2 and virulent strain 1330
The pairwise comparison was carried out to identify the
non-identical ORFs between S2 and 1330 (Table 3),
which provided useful information on the underlying
mechanisms for the attenuation of S2.
Most of the different ORFs between 1330 and S2 in
chromosome I and II had only 1 bp difference in nucleotide
Fig. 1 Circular representation of Brucella suis strain S2 chromosome I and II. Based on ProK, NR, CDD, COG, tRNA and rRNA results, two circular
diagrams of chromosomes are drawn. The concentric circles show (reading outwards): GC skew, GC content, AT skew, AT content, COG
classification of proteins on reverse and forward strand, tRNA, rRNA, CDS on reverse and forward strand, ORFs on three frames in reverse and
forward strand
Fig. 2 Comparative genomic analysis of the Brucella suis strain S2 with virulent strain 1330. The colinear analysis was carried out by Mummer. The
two chromosomes of S2 were compared separately with the corresponding chromosomes of 1330. The red showed the forward sequences,
while the blue represented the reverse sequence. The X-axis is the 1330 genomic sequence, Y-axis is the S2 genomic sequence. The colinear ana-
lysis showed that two chromosomes are almost identical; no large insertion/deletions were found
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sequence. Six ORFs had 2, 6, 8, 16, 69 and 78 bp insertion
or deletion in the genes respectively (Table 3). The insertion
or deletion in the gene caused either frameshifting (includ-
ing premature stop) or residue insertion in the coding pro-
tein. The different ORFs in S2 that encoded the same
protein sequences in other Brucella strains were labeled
‘found’ and omitted in discussions. The different ORFs la-
beled with ‘surface’ suggested that the different residue was
located on the surface of the modeled structure, which were
also omitted from the analysis (Table 3).
Known virulence associated differences
In chromosome I of S2, a 2 bp deletion caused the pre-
mature stop of an outer membrane autotransporter
OmaA. The autotransporters are secreted proteins that
can translocate themselves through the membranes to
the cell surface or to the extracellular environment. Ban-
dara et al. studied the function of this OmaA [16]. In
mice, the OmaA-deficient strain provides greater protec-
tion against the challenge of 1330 than that of B. suis
mutant strain VTRS1. The deficient strain can induce a
significantly higher level of serum IgG1 and IgG2a anti-
bodies and can be cleared quickly from the mice. Although
the OmaA activity is not necessary in the course of the
acute phase of infection of B. suis, it might still be a critical
virulent factor during the chronic phase of the infection.
Therefore, we suspected the lack of intact OmaA protein
might be the major cause for S2 virulence attenuation.
The second difference between 1330 and S2 was found
in the erythritol (ery) operon. The erythritol operon con-
tains 4 ORFs (eryA, eryB, eryC and eryD) [17]. Erythritol
metabolism by Brucella has been known to be associated
with the abortion in livestock. The high concentration of
erythritol in the foetal tissue of the animal (cattle, sheep,
goat and pig) might be advantageous for the growth of
Brucella. On the other hand, erythritol catabolism
pathway might play the important physiological roles
in bacteria growth. It has been suggested that erythrose 4-
phosphate, the precursor for the biosynthesis of aromatic
compounds, may be easily obtained from the intermedi-
ates of erythritol catabolism. Compared to 1330, a 16 bp
insertion caused the premature stop of the eryD gene in
S2. The studies on B. abortus S19 and S2308 showed that
eryD might act as a repressor of erythritol operon [17].
The consequence of eryC and eryD ORFs deletion in S19
has been studied, which reveals that they are not sufficient
or required for virulence in a murine model. No direct
correlation between erythritol metabolism and in vivo
colonization was found when S19 and 2308 strains were
compared with three genetically engineered strains related
to ery operon [18]. Considering its repressive control on ery
operon, the lack of eryD might cause the uncontrolled
erythritol catabolism. Nevertheless, its consequence on
virulence attenuation needs to be further explored.
It has been reported that S19 does not grow on TSA
(Ery). To test the growth capacity of S2 on erythritol, we
chose S19 as the control. We found that S2 was able to
grow on erythritol agar, suggesting it has the ability to
metabolize erythritol (Table 4). We compared the ge-
nomes of 1330, S2 and S19 around the ery operon. S2
and 1330 genomes have the same eryA, eryB and eryC
genes, while eryD in S2 genome encodes a premature
protein. Meanwhile, a 68 bp deletion in the region of
eryC and eryD results in an ORF encoding a putative
sugar binding protein in S19. The other genes upstream
and downstream of ery operon in these three genomes
are highly conserved, except for some mutations in the
encoded proteins (Fig. 3). Based on the analysis, the in-
viability of S19 on erythritol agar might be due to the
lack of eryC and eryD genes in the genome. A recent
paper describes a new pathway on erythritol metabolism.
Except for the known eryA, eryB, eryC and eryD genes,
two critical genes downstream of the eryD gene, TpiA2
and RpiB, in erythritol metabolism are demonstrated.
The new model strongly suggests that erythritol metab-
olism needs three isomerization reactions sequentially cat-
alyzed by EryC, TpiA2, and RpiB to produce D-erythrose-
4-P, which will be converted into glyceraldehyde-3-P and
fructose-6-P in the pentose phosphate pathway [19]. This
new model clarifies why S19 could not grow on erythritol
agar since functional eryC is lost in the genome.
Phosphatidylcholine synthase gene (PCS) in chromo-
some 2 of S2 strain had one different residue (S32L)
compared with PCS protein in 1330. In bacteria, phos-
phatidylcholine can be synthesized through either the
phospholipid N-methylation pathway or the phosphat-
idylcholine synthase pathway [20, 21]. The correlation
Table 2 Single nucleotide polymorphism comparison between
B. suis strain S2 and 1330
S2 nt
1330 nt - A C G T Total
Chromosome I
- 0 0 1 1 2
A 1 3 12 1 17
C 1 2 0 9 12
G 0 5 0 0 5
T 0 1 5 0 6
Chromosome II
- 0 1 1 0 2
A 0 1 3 0 4
C 2 1 1 3 7
G 2 3 1 3 9
T 0 1 7 0 8
Total 7 12 17 18 17 72
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Table 3 The identified non-identical proteins between attenuated strain S2 and virulent strain 1330
slno locusa S2 vs. 1330 Residue change annotation
1 BS1330_I1369 69△ hypothetical protein (found)
2 BS1330_I0234 8▽ FS IclR family transcriptional regulator (paper)
3 BS1330_I0875 6△ glycosyl hydrolase family protein(found)
4 BS1330_I2007 2▽ FS/PS outer membrane autotransporter (paper)
5 BS1330_I0045 1⊙b H→ R qoxD (found)
6 BS1330_I0093 1⊙b V→ A acnA (found)
7 BS1330_I0235 1⊙b S→ Y sugar ABC transporter, periplasmic sugar-binding protein (paper)
8 BS1330_I0501 1⊙b Q→ R ppdK (surface)
9 BS1330_I0635 1⊙b D→ A omp2b (paper)
10 1⊙b R→ H omp2b (paper)
11 BS1330_I0712 1⊙b Y→ H hypothetical protein (found)
12 BS1330_I0775 1⊙b K→ T hypothetical protein (found)
13 BS1330_I0803 1⊙b V→ A nuoF (paper)
14 BS1330_I0912 1⊙b R→Q penicillin-binding protein 1A (unknown)
15 BS1330_I1054 1⊙b H→ R acetyl-CoA hydrolase/transferase family protein (surface)
16 BS1330_I1203 1⊙b P→ S serine protease (unknown)
17 BS1330_I1213 1⊙b S→ G rplR (found)
18 BS1330_I1329 1⊙b R→ H dedA family protein (paper)
19 BS1330_I1458 1⊙b H→ R pncA (found)
20 BS1330_I1642 1⊙b A→ V glcB (surface)
21 BS1330_I1655 1⊙b V→ A hypothetical protein (found)
22 BS1330_I1684 1⊙b L→ R glmM (no direct interaction with substrate)
23 BS1330_I1742 1⊙b T→ A pyk (no direct interaction with substrate)
24 BS1330_I1896 1⊙b Y→ H sdhA (found)
25 BS1330_I2038 1⊙b E→ K GMC family oxidoreductase (surface)
26 BS1330_I2085 1⊙b A→ V sensor histidine kinase BvrS (unknown)
27 BS1330_I2149 1⊙b A→D PhoH family protein (found)
28 BS1330_I0973 1⊙b A IS711, transposase orfA
29 BS1330_I1083 1⊙b P luciferase family protein
30 BS1330_I1087 1⊙b E tgt
31 BS1330_I1302 1⊙b I cobN
32 BS1330_I1971 1⊙b L short chain dehydrogenase
33 BS1330_I2107 1⊙b I hypothetical protein
34 BS1330_II0476 78△ pyridine nucleotide-disulfide oxidoreductase family protein (found)
35 BS1330_II0860 16△ FS/PS eryD (paper)
36 BS1330_II0148 1▽ FS 3-hydroxyisobutyrate dehydrogenase (paper)
37 BS1330_II0683 1△ sugar ABC transporter ATPase (found)
38 BS1330_II0999 1▽ amidase (unknown)
39 BS1330_II1074 1▽b PS IclR family transcriptional regulator (paper)
40 BS1330_II0278 1⊙b A→ T nnrR (surface)
41 BS1330_II0440 1⊙b A→ E glpK (surface)
42 BS1330_II0441 1⊙b T→ A major facilitator family transporter (found)
43 BS1330_II0533 1⊙b P→Q oligopeptide ABC transporter, periplasmic oligopeptide-binding protein (paper)
44 1⊙b S→ G oligopeptide ABC transporter, periplasmic oligopeptide-binding protein (paper)
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between bacterial virulence and membrane phosphat-
idylcholine has been reported in L. pneumophila and A.
tumefaciens [22–24]. The cell envelope of the Brucella
contains phosphatidylethanolamine and phosphatidylcho-
line. Although the phosphatidylcholine level in bacterial
membrane does not affect some major virulence proper-
ties of Brucella such as invasion, intracellular traffic, and
intracellular replication, it is necessary to maintain a
chronic infection in mice [25, 26]. A systematic study
on phosphatidylcholine synthase from S. meliloti was
performed by alanine scanning mutagenesis. Protein se-
quence alignment of PCSs from several bacteria species
showed that only five of eight residues at position 32
are serine. Changing the conserved residues close to
position 32 causes about 20 % decrease in PCS activity
[27]. Further studies are needed to explore if the muta-
tion at position 32 affects the PCS activity, which might
decrease S2 virulence.
Peptidoglycan is a major component of the bacterial
cell wall. Its main function is to preserve the cell integ-
rity and resist osmotic pressure [28]. It has been shown
that peptidoglycan synthesis genes affect bacterial shape,
elongation, and cell division [29]. Therefore, disruption
of peptidoglycan synthesis might affect the survival rate
of the bacteria in the host. UDP-N-acetylglucosamine
(UDP-GlcNAc) is one of the key building blocks in
peptidoglycan biosynthesis [30]. The second step in the
formation of UDP-GlcNAc is the interconversion of
glucosamine-6-phosphate to glucosamine-1-phosphate,
which is catalyzed by the enzyme phosphorglucosamine
mutase (PNGM). A growing body of research suggests
the importance of PNGM in bacterial virulence and infect-
ivity [31–33]. The different residue in PNGM between S2
and 1330 was located at position 250. Although the
residue was close to the substrate binding site, it did
not interact with the substrate. The biochemical studies
are needed to fully define the function of this residue
on PNGM activity and bacterial virulence.
Pyruvate kinase (PK), the key enzyme in the glycolysis,
is important for controlling the concentrations of glyco-
lytic intermediates, biosynthetic precursors and nucleoside
triphosphates in the cells. Pyruvate kinase transfers the
phosphoryl group of phosphoenolpyruvate to ADP to yield
pyruvate and ATP. Most eukaryotic PKs can be allosteri-
cally activated by fructose 1,6-bisphosphate (FBP), while
bacterial PK could be activated by either FBP or AMP/
sugar monophosphates [34]. The bacteria carrying the im-
paired PK activity might exhibit severe attenuation as
Table 3 The identified non-identical proteins between attenuated strain S2 and virulent strain 1330 (Continued)
45 BS1330_II0567 1⊙b S→ L pcs (paper)
46 BS1330_II0571 1⊙b A→ P peptide ABC transporter, periplasmic peptide-binding protein (found)
47 BS1330_II0782 1⊙b V→ A hypothetical protein (found)
48 BS1330_II0786 1⊙b M→ T fadB (found)
49 BS1330_II0805 1⊙b E→ K glucuronate isomerase (interface)
50 BS1330_II0844 1⊙b N→ D aminotransferase, class III (surface)
51 BS1330_II0911 1⊙b W→ R oxidoreductase, molybdopterin-binding (unknown)
52 BS1330_II0980 1⊙b S→ P WD repeat-containing protein (unknown)
53 BS1330_II0990 1⊙b C→W hypothetical protein (found)
54 BS1330_II1031 1⊙b P→ S lepA (unknown)
55 BS1330_II1137 1⊙b M→ L fliF (paper)
56 BS1330_II0646 1⊙b L branched-chain amino acid ABC transporter, ATP-binding protein
57 BS1330_II0913 1⊙b G outer surface protein
58 BS1330_II0945 1⊙b A branched-chain amino acid ABC transporter, periplasmic amino acid-binding protein
59 BS1330_II1103 1⊙b A hypothetical protein
Abbreviations and symbols: ⊙ = bp Difference, ▽ = bp Deletion, △ = bp insertion, FS frameshift, PS premature stop; paper: see discussion in the paper
aRepresentative locus from 1330 genomes
bsingle nucleotide polymorphism within ORF
Table 4 Effect of erythritol on growth of Brucella suis strain S2 and B. abortus strain S19
Strain TSA TSA (Ery)
107 106 105 104 103 102 101 107 106 105 104 103 102 101
S19 C C +++ +++ ++ + ± ± — — — — — —
S2 C C +++ +++ +++ ++ ++ C C +++ +++ +++ ++ ++
Estimate of growth: C, confluent; +++, numerous individual colonies; ++, more than 100 colonies; +, 10 to 100 colonies; ±, 1 to 10 colonies
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suggested in the study in C. Neoformans [35]. In chromo-
some I of S2, there was one residue different (T462A) in
PK compared to that in 1330. Based on result of the Pro-
tein Databank search by blastp program, Brucella PK
shared some similarities with PKs from other species, such
as human, rabbit, B. Stearothermophilus, S. aureus et al. In
the structure of human pyruvate kinase isozyme M2, the
corresponding threonine at position 462 was close to the
FBP binding site and interacted with FBP through two
water molecules [36]. The threonine residue is highly con-
served in many PKs, except for the serine in E. coli. Both
threonine and serine contain hydroxyl groups, which
might be important for its interaction with the activator.
A study demonstrates that S2 grows normally in the
medium containing glucose as the only carbon source [37].
We, therefore, suspected the mutant on PK might not be a
major reason for S2 attenuation. Further biochemical stud-
ies are still necessary to clarify this conclusion.
Although Brucella spp. is considered typically as non-
motile, a study demonstrates that flagellar genes are ne-
cessary for the assembly of a functional flagellum [38, 39].
B. melitensis with fliF mutant is unable to replicate in
macrophages and HeLa cells, suggesting the Brucella
flagellar genes might be related to virulence [40]. Another
study shows that in the early log phase of its growth in
2YT nutrient broth, B. melitensis expresses genes corre-
sponding to the basal (MS ring) and the distal parts of the
flagellar apparatus. A polar and sheathed flagellar struc-
ture has been observed under transmission electron
microscopy. Although the mutations encoding different
parts of the flagellum structure do not show a discernible
phenotype when compared with the wild-type strain in
cellular infection models, all these mutants are attenuated
in mice infected via the intraperitoneal route in 4 weeks
after infection [41]. We found a mutation in fliF protein
(M544L) located in MS ring. Whether the mutation de-
creases the virulence of S2 awaits further studies.
Other different proteins found between S2 and 1330
Two IclR regulatory genes in S2 were different from those
in 1330. The IclR regulatory gene located in chromosome
I lacked 8 bp that began at ATG, causing the loss of the
coding protein. The other different IclR regulatory gene
located in chromosome II had a 1 bp deletion, resulting in
the premature stop in the coding protein. Members of the
IclR transcription regulator family regulate a variety of
metabolic processes in various microorganisms [42]. In
one study, B. melitensis 16M mutations in AraC, ArsR,
Crp, DeoR, GntR, IclR, LysR, MerR, RpiR and TetR were
constructed. GntR and LysR mutants showed the de-
creased virulence [43]. Two different IclR regulatory genes
found in S2 genome were correspondent to IclR5 and
IclR6 in the study. Therefore, the lack of these two IclR
regulatory genes might not be the major cause for S2
attenuation.
In chromosome I of S2, Omp2b had two residues dif-
ferent from that in 1330. Omp2b is bacterial porins
present in the outer membrane of Brucella. The differ-
ences in the Omp2b variants are located in the predicted
external loops of the porin [44]. The first different resi-
due (D79A) is highly conserved in different Brucella
strains, while the second different residue (R225H) is not
strictly conserved. Omp2b is present in virulent B. abortus,
B. melitensis and B. suis strains that are pathogenic to
Fig. 3 Comparison of the upstream and downstream genomic regions around ery operon of B. suis strain 1330, B. suis strain S2 and B. abortus
strain S19
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humans, but is absent in non-pathogenic B. ovis [45]. Bac-
terial porins have been reported to be involved in apoptosis
modulation [46–48]. Expression of B. melitensis Omp2b in
yeast prevents the cell from death induced by the mamma-
lian pro-apoptotic protein Bax [49]. No further functional
studies have been reported on Brucella Omp2b.
High-affinity binding protein-dependent ABC trans-
porter consists of a high-affinity periplasmic substrate-
binding subunit, two hydrophobic membrane subunits
and two additional cytoplasmic subunits. ATP hydrolysis
by associated ATPase provides the energy for substrate
accumulation across the inner membrane against the
concentration gradient. Periplasmic substrate-binding
subunits are composed of two separate but similarly
folded globular domains, which are connected by a
hinge region made of two or three short polypeptide
segments [50]. In S2 chromosome I, 1 bp difference in
periplasmic sugar-binding protein caused one residue
difference (S97Y) in protein sequence compared with that
in 1330 strain. The sequence alignment with structure-
solute receptor GacH of Streptomyces glaucescens (Protein
Databank accession number: 3JZJ [51]) showed that this
residue was located very close to the substrate binding site.
Due to the bulky structure of tyrosine, we suspected the
mutation might affect the sugar binding affinity or prefer-
ence of the protein. The comparative proteome study on
B. melitensis vaccine strain Rev 1 and virulent strain 16 M
reveals that four sugar-binding proteins are differentially
expressed in Rev 1, although these two strains have similar
physical properties in biotyping tests [52]. Therefore, it is
possible that the substrate preference change might help
bacteria adapt to different growth conditions.
In S2 chromosome II, 2 bp differences resulted in 2
residues difference in oligopeptide ABC transporter. The
first different residue (S136G) existed in other Brucella
strains, while the other different residue was only seen
in S2 (P284Q). Bacteria utilize peptides as a source of
amino acids, carbon, nitrogen, and/or energy. A variety
of peptide uptake systems mediate the translocation of
peptides across the bacterial cytoplasmic membrane.
Recent studies show that OppA possesses preference in
substrate peptide. E. coli OppA prefers positively charged
peptides with three or four amino acids in length. How-
ever, other studies also suggest that the substrate prefer-
ence of the peptide uptake systems are more complicated
[53, 54]. The sequence alignment with the homologous
structure of oligopeptide-binding protein from Salmonella
typhimurium [55] showed that residue 284 was located
close to the substrate binding site, but not involved in dir-
ect interaction with the substrate. Compared with other
available structures of oligopeptide-binding proteins,
the residue 284 of OppA protein can be glutamate (S.
typhimurium), serine (E. coli), alanine (E. coli) or tyrosine
(B. Pseudomallei). Meanwhile, two oligopeptide-binding
proteins were encoded in 1330 genome, which shared
84 % similarity in protein sequences. The residue at 284 is
aspartate in the other sequence, suggesting this residue
was not conserved well in different bacteria. ATP-Binding
Cassette Transporter in Brucella ovis is shown to be essen-
tial in mice [56]. The ΔabcAB mutant strain can trigger
host serologic responses similar to the WT strain and a
significant cellular host response [57].
One residue different in S2 was found in a DedA family
protein. The DedA family proteins are integral inner
membrane proteins, which are present in nearly all species
of bacteria. E. coli encodes 8 DedA proteins. Although
each of them is nonessential, they are collectively essential
[58]. An E. coli mutant with two dedA genes deletion
(ΔyghB/ΔyqjA) fails to complete cell division or grow at el-
evated temperatures [59]. B. burgdorferi possesses only
one dedA gene. The gene deletion results in imbalanced
membrane phospholipid composition, which is required
for proper cell division and envelope integrity [60]. No
functional clue was suggested for Brucella DedA so far.
We identified a difference at residue 576 between S2
and 1330 in a putative molybdopterin-binding oxidore-
ductase. Members of the molybdopterin oxidoreductase
family include formate dehydrogenase, nitrate reductase,
DMSO reductase, TMAO reductase, pyrogallol hydroxy-
transferase and arsenate reductase. The protein in S2
showed about 40 % similarity with formate dehydrogen-
ase H from E. coli at residues 54–420, as suggested by
the protein databank search with blastp. The residues in-
volved in Mo binding are conserved [61]. No significant
sequence similarity was found between these two proteins
around residue 576.
A 1 bp insertion caused the premature stop of 3-
hydroxyisobutyrate dehydrogenase in S2. 3-
hydroxyisobutyrate dehydrogenase, a key enzyme for the
metabolism of valine and some keto-bodies, exists widely
in bacteria, yeast, and mammalian tissue. It catalyzes the
reversible conversion of 3-hydroxyisobutyrate to methyl-
malonate semialdehyde [62]. Although the enzymatic
properties of 3-hydroxyisobutyrate dehydrogenase have
been studies in several organisms, its relevance to bacterial
virulence awaits further studies.
NADH-quinone oxidoreductase subunit 1 (NuoF) in
S2 had one different residue compared with that of 1330
strain. NuoF is part of the hydrophilic fragment of
NADH dehydrogenase I, which represents the electron
input part of the enzyme NADH: ubiquinone oxidoreduc-
tase. It couples electron transport to proton translocation
across the membrane, which is partially responsible for
generating the proton gradient necessary for ATP produc-
tion. NADH: ubiquinone oxidoreductase serves as both a
proton pump and an entry point for electrons into the
respiratory chain [63]. Currently, no bacterial virulence
is associated with this gene.
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One residue difference was found in lepA gene between
S2 and 1330. LepA protein encoded by this gene exists in
most of the bacterial genomes [64]. Although lepA knock-
out strain of E. coli [65] and Staphylococcus aureus [66]
are viable, the gene product might be necessary for bac-
teria survival under certain growth conditions [67].
There are other different proteins between S2 and
1330 (labeled unknown in Table 3). When we analyzed the
sequences, we did not find any functional implications of
the proteins in bacteria. Therefore, further studies are
needed to clarify their links to virulence attenuation of S2
strain.
Conclusion
In this report, we sequenced the attenuated strain Brucella
suis S2 genome and performed comparative genome ana-
lysis between S2 and virulent strain 1330. During the ana-
lysis, we found out 59 different ORFs between these two
strains. Of these different ORFs, several have been reported
to be related to Brucella virulence, such as outer membrane
autotransporter, eryD. The proteins encoded by some of
the different genes have been suggested to be essential for
bacteria growth, such as dedA, phosphorglucosamine mu-
tase and phosphatidylcholine synthase. These gene prod-
ucts might be responsible for the utilization of the materials
from the environment, which are necessary for bacteria
growth. We found several mutations in peptide-binding
ATP transporter and sugar-binding ATP transporter, but
their roles on S2 attenuation could not be ruled out without
further investigation.
It has been shown that the high concentration of
erythritol in the foetal tissues of cattle, sheep, goats and pigs
might be beneficial for the growth of Brucella. Erythritol ca-
tabolism pathway may play important physiological roles in
Brucella. The studies in S19 and S2308 showed that eryD
might act as the repressor of erythritol operon [17]. In our
experiment, we found that S2 but not S19 could grow in
the media supplemented with erythritol, suggesting S2 has
the ability to metabolize erythritol. Therefore, further inves-
tigation on the function of the eryD gene is necessary to
clarify its relevance to virulence attenuation.
Although we identified some target proteins that might
be related to the virulence, most of the identified proteins
have not been investigated in Brucella. Therefore, all these
genes have to be examined individually to ensure their re-
lationships with the virulence. The modification of the
genes identified in our study will help to reduce residual
virulence, which is critical to developing more efficient
Brucella vaccine strains.
Methods
Strain and genomic DNA preparation
The S2 used in sequencing was obtained from the China
Institute of Veterinary Drugs Control. Total genomic
DNA was extracted using the DNeasy Blood and Tissue
Kit (QIAGEN, China Ltd., China). The DNA was frag-
mented by nebulization, and fragments ranging from
400 to 600 bp were extracted from an agarose gel after
size-fractionation, and then adaptors were added accord-
ing to Illumina Sample Preparation Guide.
Genome sequencing and assembly
After sequencing with Illumina Hiseq2000, 50,941,654
paired-end (2*101 bp) reads were obtained. Base calling
was performed with the software CAVASA. There were
41,608,314 paired reads passed the filter, which provided
coverage of chromosome of ~1000-fold. Reads were as-
sembled into contigs and scaffolds using SOAP de-novo
(Release 1.04) [68]. Assembled contigs were compared
to the published genome sequence of B. suis strain 1330
(NC_017250.1, NC_017251.1) using BLAT v.34 [69]. The
order and the orientation of the assembled contigs were
determined in accordance with the control genome.
Based on the extensive similarities between the pub-
lished genomes of Brucella, PCR primers were designed
to link the gaps between two neighboring contigs. The
leftover gaps were sequenced separately by conventional
Sanger sequencing. The Illumina sequence reads for the
genomes are deposited to NCBI, with the accession
number of SAMN03068300.
Gene prediction and annotation
Gene prediction was established with Glimmer 2.0 using
the default settings [70]. All the predicted CDS and pu-
tative intergenic sequences were subjected to further
manual inspections. Exhaustive BLAST searches with an
incremental stringency against the NCBI non-redundant
protein database were performed to determine the hom-
ology of the predicted coding sequences. Translational
start codons were identified based on protein homology,
proximity to the ribosome-binding site, relative positions
to predicted signal peptide and putative promoter se-
quences. We also classified the putative proteins accord-
ing to the COG database search results. Transfer RNAs
were predicted with the tRNAscan-SE software. The repeat
sequences were predicted by Trf program [71]. The results
showed 55 and 23 tandem sequences in chromosome I and
II. The average copy number is 2.79 and 2.86.
All the S2 proteins predicted have been compared to
KEGG bacterial gene set with KAAS (KEGG Automatic
Annotation Server http://www.genome.jp/tools/kaas/)
program by BBH (Bi-directional best hit) method to
map the genes into bacterial pathways automatically.
Comparative genomic analysis
MUMmer 3.0 program was used to investigate the dif-
ferences between the genome sequences of 1330 and
S2 with the default parameters [72]. The genomes
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were first automatically compared for SNPs and indels
by MUMmer3.0. Then SNPs between 1330 and S2 were
called by home-brew perl scripts. We classified SNPs as
intergenic, frameshift and premature stop according to
their positions and functions, and also counted the num-
bers of synonymous substitutions and non-synonymous
substitutions. To identify potential genes that were differ-
ent between 1330 and S2, we compared S2 genome se-
quences using blastp program with proteins download
from NCBI RefSeq database.
S2 and S19 erythritol sensitivity test
The Trypticase-soy agar plates in the presence of 1 mg/ml
erythritol [TSA (Ery)] plates were prepared [73]. The auto-
claved TSA was cooled to 47 °C, and the appropriate
amount of erythritol was added and mixed. The plates
were poured. S2 and S19 were grown on TSA slants at
37 °C for 24 h and resuspended in saline, and were tested
by placing 20 μl of tenfold dilutions (107, 106, 105, 104,
103, 102 and 101 CFU/ml) of the bacteria resuspension on
TSA and TSA (Ery) plates and incubated at 37 °C. Plates
were examined for 2 to 5 days. The effect of erythritol on
the growth of S2 was estimated from the size of the col-
onies on the test plates in comparison with the control
plates (S2 and S19 inoculated on TSA plates and S19
inoculated on TSA (Ery) plates). The experiments were
repeated three times.
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